CALDA president Phyllis Mervine had a sharp response to a "Eugene Weekly" guest editorial, written by a doctor who claimed there was little chance of any one suffering serious effects from Lyme disease. Mervine suggested the doctor "examine the evidence herself and not accept at face value the interpretation of powerful, self-appointed authorities who have vested interests to protect."

.

.

.

.

From the Eugene Weekly, Feb. 18, 2010:

Flawed Guidelines
Lyme disease treatment options limited by conflicts and questionable science
By Phyllis Mervine

In her Viewpoint Jan. 28, Dr. Sarah Henderson aligns herself with the flawed Lyme disease guidelines of the Infectious Diseases Society of America (IDSA). The IDSA treatment guidelines are highly restrictive, ineffective, and leave seriously ill patients without effective treatment options. The IDSA guidelines panel which developed the guidelines had serious and significant commercial conflicts of interest with vaccine manufacturers, Lyme diagnostic kit distributors, and insurance companies. The panel did not consider the interests of patients and their treating physicians, with the result that it placed commercial interests above quality of patient care.

Read the rest of the story here.